These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 6487440
21. Halothane-caffeine contracture testing in neuromuscular diseases. Heiman-Patterson TD, Rosenberg H, Fletcher JE, Tahmoush AJ. Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516 [Abstract] [Full Text] [Related]
22. The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility. Britt BA, Endrenyi L, Kalow W, Peters PL. Can Anaesth Soc J; 1976 Nov; 23(6):624-35. PubMed ID: 990979 [Abstract] [Full Text] [Related]
27. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone]. Fiege M, Wappler F, Scholz J, von Richthofen V, Brinken B, Schulte am Esch J. Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864 [Abstract] [Full Text] [Related]
31. Cystathionine β-synthase-derived hydrogen sulfide is involved in human malignant hyperthermia. Vellecco V, Mancini A, Ianaro A, Calderone V, Attanasio C, Cantalupo A, Andria B, Savoia G, Panza E, Di Martino A, Cirino G, Bucci M. Clin Sci (Lond); 2016 Jan; 130(1):35-44. PubMed ID: 26460077 [Abstract] [Full Text] [Related]
32. [Detection of peranesthetic malignant hyperthermia by muscle contracture tests and NMR spectroscopy]. Kozak-Reiss G, Gascard JP, Redouane-Bénichou K. Ann Fr Anesth Reanim; 1986 Jan; 5(6):584-9. PubMed ID: 3826791 [Abstract] [Full Text] [Related]
34. [Diagnosis of susceptibility to malignant hyperthermia using the in vitro contracture test]. Klein W, Spiess-Kiefer C, Küther G, Pongratz D, Lehmann-Horn F. Anaesthesist; 1987 Dec; 36(12):685-91. PubMed ID: 2830805 [Abstract] [Full Text] [Related]
36. Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia. Paasuke RT, Brownell AK. JAMA; 1986 Feb 14; 255(6):769-71. PubMed ID: 3944979 [Abstract] [Full Text] [Related]
37. In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine tests. Ording H, Skovgaard LT. Acta Anaesthesiol Scand; 1987 Jul 14; 31(5):458-61. PubMed ID: 3630590 [Abstract] [Full Text] [Related]